To investigate whether EZH2 regulated HCC progression by suppressing miR-381, we firstly utilized an open access clinical database, GEPIA, to analyze EZH2 expression in HCC, which showed that EZH2 was highly expressed in HCC samples (Figure 6(a)). The gene discussed is EZH2; the disease is hepatocellular carcinoma.